Evidence map›Paper›PMID 22989748›Full record

ArticleBiochemical and biophysical research communications2012

Recombinant expression of TLR5 proteins by ligand supplementation and a leucine-rich repeat hybrid technique.

Minsun Hong, Sung-Il Yoon, Ian A Wilson

Abstract read
In one paragraph

Article in Biochemical and biophysical research communications, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Purification, crystallization and X-ray crystallographic studies of flagellin from Pseudomonas aeruginosa.Acta crystallographica. Section F, Structural biology communications · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 2 countries.

Minsun Hong *Department of Molecular Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Sung-Il Yoon *Department of Molecular Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Ian A WilsonDepartment of Molecular Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Scripps Research Institute · US

Funding

Structural Basis of T Cell Receptor RecognitionR37AI042266 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI WILSON, IAN A · 2003 to 2012
$5.8M
Structural basis of TLR and NLR recognition and signalingR01AI042266 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI WILSON, IAN A · 1998 to 2017
$3.7M
NIAID NIH HHS AI042266NIAID NIH HHS R01 AI042266NIAID NIH HHS R37 AI042266
6 · The paper itself

Abstract

Vertebrate TLR5 directly binds bacterial flagellin proteins and activates innate immune responses against pathogenic flagellated bacteria. Structural and biochemical studies on the TLR5/flagellin interaction have been challenging due to the technical difficulty in obtaining active recombinant proteins of TLR5 ectodomain (TLR5-ECD). We recently succeeded in production of the N-terminal leucine rich repeats (LRRs) of Danio rerio (dr) TLR5-ECD in a hybrid with another LRR protein, hagfish variable lymphocyte receptor (VLR), and determined the crystal structure of its complex with flagellin D1-D2-D3 domains. Although the structure provides valuable information about the interaction, it remains to be revealed how the C-terminal region of TLR5-ECD contributes to the interaction. Here, we present two methods to obtain recombinant TLR5 proteins that contain the C-terminal region in a baculovirus expression system. First, production of biologically active full-length drTLR5-ECD was substantially enhanced by supplementation of expression culture with purified flagellin proteins. Second, we designed TLR5-VLR hybrids using an LRR hybrid technology by single and double LRR fusions and were able to express diverse regions of drTLR5-ECD, allowing us to detect a previously unidentified TLR5/flagellin interaction. The drTLR5-VLR hybrid technique was also successfully applied to human TLR5-ECD whose expression has been highly problematic. These alternative TLR5 expression strategies provide an opportunity to obtain a complete view of the TLR5/flagellin interaction and can be applied to other LRR proteins.

Indexed as

ProteinsAmino Acid SequenceFlagellinHumansLeucine-Rich Repeat ProteinsLigandsMolecular Sequence DataProtein EngineeringProtein Structure, TertiaryRecombinant Fusion ProteinsToll-Like Receptor 5FlagellinLeucine-Rich Repeat ProteinsLigandsProteinsRecombinant Fusion ProteinsToll-Like Receptor 5

Identifiers

PMID22989748
PMCPMC3823237
OpenAlexW1997791645

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.